![](/img/cover-not-exists.png)
EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study
Robert Pirker, Jose R Pereira, Joachim von Pawel, Maciej Krzakowski, Rodryg Ramlau, Keunchil Park, Filippo de Marinis, Wilfried EE Eberhardt, Luis Paz-Ares, Stephan Störkel, Karl-Maria Schumacher, AnjVolume:
13
Year:
2012
Language:
english
DOI:
10.1016/s1470-2045(11)70318-7
File:
PDF, 872 KB
english, 2012